Bristol Myers Squibb (BMY) Advances But Underperforms Market: Key Facts
Bristol Myers Squibb (BMY) closed at $49.95 in the latest trading session, marking a +0.46% move from the prior day.
The Magnificent 7 Dividend Stocks Every Passive Income Investor Should Own
24/7 Wall St. Insights Dividend stocks are starting to outperform in the second half of 2024.
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday
Shares of several drugmakers and biotechnology firms moved higher on Wednesday, notching some of the day's top performances in the S&P 500.
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
The benchmark S&P 500 index is way up over the past year, but some of its dividend-paying components haven't participated in the gains. Bristol Myers Squibb's dividend offers a high yield that coul...
Bristol Myers' (BMY) HCC Combo Drug Accepted for FDA Review
Bristol Myers' (BMY) application seeking approval for the Opdivo/Yervoy combo to treat unresectable hepatocellular carcinoma gets accepted for FDA review.
Bristol Myers' (BMY) Breyanzi Label Expansion Application Validated
Bristol Myers' (BMY) application to expand Breyanzi's label for the treatment of adult patients with relapsed or refractory follicular lymphoma gets EMA validation.
3 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Bristol Myers Squibb doesn't sell anti-obesity drugs, but it can keep raising its dividend payout without them. Shares of Dow Inc. offer a yield above 5%, and there's a good chance the company can ...
Where Will Bristol Myers Squibb Be in 5 Years?
Bristol Myers Squibb will face major losses of patent exclusivity by 2029. BMS has launched a number of brand-new approvals to replace older products.
All You Need to Know About Bristol Myers (BMY) Rating Upgrade to Buy
Bristol Myers (BMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BMY vs. VRTX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb (BMY) or Vertex Pharmaceuticals (VRTX). But which of these two stocks...
Bristol Myers (BMY) Gains 16% in a Month: Should You Buy or Wait?
Bristol Myers' (BMY) impressive second-quarter results propelled the stock in the past month. However, we advise investors not to be over-optimistic at this point and look before they leap.
The Market May Be Overvalued, But These 3 Value Picks Are Ready To Boom
The concept of value stocks are easy to understand.
Best Dividend Stocks Yielding Over 5% to Buy Now
24/7 Wall St. Insights With inflation starting to be tamed, dividend stocks will be in big demand as rates drop.
BMY vs. VRTX: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Vertex Pharmaceuticals (VRTX). But which of these two companies is...
Related Companies